Frequencies for first 10,000 rows of lit_ref variable in demo2017q4 dataset : Literature Reference | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 9,190 91.90 91.90 , ALLRED J, HURRIA A, JATOI A, LAFKY .. | 1 0.01 91.91 , BLAZQUEZ J, MORENO A, BARCENA R, GI.. | 1 0.01 91.92 , BUCHHOLZ S AND KACZMAREK I. DE-NOVO.. | 1 0.01 91.93 , CARMICHAEL L, KIM K, PETERSON C, YA.. | 1 0.01 91.94 , CHIKOVA I, ISUPOVA E, DUBKO M, MASA.. | 1 0.01 91.95 , CHIKOVA I, ISUPOVA E, DUBKO M, MASA.. | 1 0.01 91.96 , COPLIN W, LIN Y, FRANKEL M, LYDEN P.. | 1 0.01 91.97 , DESJARDINS A, REARDON D, PETERS K, .. | 1 0.01 91.98 , FINE D, HAAS M, MAGDER L AND PETRI .. | 5 0.05 92.03 , FORMANN E, LAFERL H, GSCHWANTLER M,.. | 1 0.01 92.04 , FORMANN E, LAFERL H, GSCHWANTLER M,.. | 2 0.02 92.06 , GORLICH D, NOWAK D, SPIEKERMANN K, .. | 13 0.13 92.19 , HARA, T, SHIBATA Y, NAKAMURA N, NAK.. | 1 0.01 92.20 , HIRAMATSU K, MAEDA A, SAKAMOTO E, A.. | 1 0.01 92.21 , HUBBARD J, O^NEIL B, JONKER D, STAR.. | 1 0.01 92.22 , JANKU F, HELGASON T, GILCREASE M, B.. | 1 0.01 92.23 , JINDRA P, HES O, SVECOVA M, KLABOCH.. | 1 0.01 92.24 , KAMEI K, OGURA M, ISHIKURA K AND IT.. | 1 0.01 92.25 , KATO S, HUANG H, NAING A, HOLLEY V,.. | 1 0.01 92.26 , KOEBERLE D, SCHACHER S, HAYOZ S, WI.. | 1 0.01 92.27 , KOGA M, NAKAGAWARA J, SHIOKAWA Y, Y.. | 1 0.01 92.28 , KOGA, M. NAKAGAWARA, J. SHIOKAWA, Y.. | 1 0.01 92.29 , LAUTENSCHLAGER I AND KOSKINEN P PRO.. | 1 0.01 92.30 , LI F, LI Z, YI S, YU Z XING L, XU Y.. | 1 0.01 92.31 , LIU L, FENG Y, WANG W, WANG J, LI G.. | 1 0.01 92.32 , MASCHMEYER G, GANSER A, HEIDER A, V.. | 1 0.01 92.33 , MASCHMEYER G, GANSER A, HEIDER A, V.. | 1 0.01 92.34 , MODEST D, VON WEIKERSTHAL L, DECKER.. | 1 0.01 92.35 , MODEST D, VON WEIKERSTHAL L, DECKER.. | 1 0.01 92.36 , MOUGHAN J, MILLER B, XIAO Y, MATUL.. | 1 0.01 92.37 , NAKAGISHI Y, KASAI K, YAMASAKI Y, M.. | 1 0.01 92.38 , NARCISO-SCHIAVON J, CARVALHO-FILHO .. | 1 0.01 92.39 , NARDONE V, BOTTA C, CROCI S, TINI P.. | 1 0.01 92.40 , NASTI G, ROSATI G, CARLOMAGNO C, RO.. | 1 0.01 92.41 , NIKOLAOU M, KALBAKIS K, POLYZOS A, .. | 1 0.01 92.42 , PLUARD T, URRUTICOECHEA A, FARCI D,.. | 1 0.01 92.43 , ROBAK T, COIFFIER B, DELGADO J, MAR.. | 1 0.01 92.44 , ROJAS-HERNANDEZ C, FEKRAZAD H, BANS.. | 1 0.01 92.45 , ROSSARO L, HU K, PATEL K, TILLMANN .. | 1 0.01 92.46 , SHI Y, CHEN L, XIAO X AND DAI G CLI.. | 1 0.01 92.47 , SUTTON E, NESBIT S, WHITE J, PARKER.. | 1 0.01 92.48 , VERMEIJ J, BROUWER M, ROOS Y, NEDER.. | 1 0.01 92.49 , VERMEIJ J, BROUWER M, ROOS Y, NEDER.. | 7 0.07 92.56 , VINOD N AND JOSHI M A CASE OF PULMO.. | 1 0.01 92.57 , WANG J, MAU-SORENSEN M, BIRRER M, W.. | 1 0.01 92.58 , WEST N, SEBAG-MONTEFIORE D, MYINT A.. | 1 0.01 92.59 , WINTER K, MILLER B, XIAO Y, JHINGRA.. | 2 0.02 92.61 , WINTERK, MILLER B, XIAO Y, JHINGRAN.. | 1 0.01 92.62 , WOJNER A AND GROTTA J CLOTBUST: DES.. | 1 0.01 92.63 , YAMAGUCHI K, KOMATSU Y, MURO K, NIS.. | 1 0.01 92.64 1) ARELLANO AL, MARTIN M, MONERRIS M,.. | 1 0.01 92.65 A HOXHA. PREGNANCY AND ANTI-TNFALPHA .. | 1 0.01 92.66 A SUZUKI. A CASE OF CONTAGIOUS IMPETI.. | 1 0.01 92.67 ABE Y.. A CASE OF MILD CONGENITAL HYP.. | 1 0.01 92.68 ABU-SAYEEF MIRZA, JEFFREY E. LANCET, .. | 1 0.01 92.69 ACOSTA FR, BENITEZ ML, ODDINO J, LEMA.. | 1 0.01 92.70 ACOSTA FR, BENITEZ ML, ODDINO J, LEMA.. | 3 0.03 92.73 ADAM, J.. SAFE ADMINISTRATION OF DOCE.. | 1 0.01 92.74 ADAMCZYK M, MICHALSKA-JAKUBUS M, PIER.. | 1 0.01 92.75 ADAMS PS, CASSARA A. DEXMEDETOMIDINE-.. | 1 0.01 92.76 ADLER, N.. PIPERACILLIN-TAZOBACTAM-IN.. | 1 0.01 92.77 AFFOLTER K, SAMOWITZ W, BOYNTON K, KE.. | 1 0.01 92.78 AFFOLTER K, SAMOWITZ W, BOYNTON K, KE.. | 1 0.01 92.79 AFFOLTER K,BOYNTON K,SAMOWITZ W,DOWNS.. | 1 0.01 92.80 AFFOLTER K,BOYNTON K,SAMOWITZ W,KELLY.. | 1 0.01 92.81 AFFOLTER K,SAMOWITZ W,BOYNTON K,KELLY.. | 1 0.01 92.82 AGUILAR-ORTIZ M, LEON J, VELASCO-HIDA.. | 1 0.01 92.83 AGULNIK A, KELLY DP, BRUCCOLERI R, YU.. | 1 0.01 92.84 AHMAD J, ODIN J, HAYASHI P, ET AL. ID.. | 1 0.01 92.85 AIDA A, KUBOTA N, YAMAUCHI T, KADOWAK.. | 1 0.01 92.86 AKIKO MATSUYOSHI ET AL. A CASE OF SLO.. | 1 0.01 92.87 AKIYAMA N, YOKOMURA K, NOZUE T, ABE T.. | 3 0.03 92.90 AKNOUCHE F, ET AL.. MULTIPLE DRUGS SU.. | 1 0.01 92.91 AKNOUCHE, F.. SUICIDE OF A NURSE IN A.. | 1 0.01 92.92 AL-ALI H, JAEKEL N, JUNGHANSS C, MASC.. | 1 0.01 92.93 ALEX M, MADDEN MM. AN UNUSUAL ETIOLOG.. | 1 0.01 92.94 ALEXANDER ST, KATTULA D, MANNAM P, IY.. | 1 0.01 92.95 ALHASHEM H. PERSISTENT HEMORRHAGE AFT.. | 1 0.01 92.96 ALLEN K M, CRAWFORD V B, CONAGLEN J V.. | 1 0.01 92.97 ALSHAMI J, GUIOT MC, OWEN S, KAVAN P,.. | 1 0.01 92.98 ALYAHYA B, FRIESEN M, NAUCHE B, LALIB.. | 1 0.01 92.99 ALYAHYA B, FRIESEN M, NAUCHE B, LALIB.. | 1 0.01 93.00 ALZAID K, JONES BD. A CASE REPORT OF .. | 1 0.01 93.01 ALZUBAIDI M, JOHNSON-DAVIS KL, CAMPBE.. | 1 0.01 93.02 AMAZAN E, DESBOIS N, FIDELIN G, BAUBI.. | 1 0.01 93.03 AMER S, GIOVANNI DP, NGUYEN C. A RARE.. | 1 0.01 93.04 ANAYA Y, DOUGLAS M, LETOURNEAU J, CAK.. | 3 0.03 93.07 ANDRIANI A, MONTANARO M, BRECCIA M, N.. | 1 0.01 93.08 ANDUJAR-PLATA P, FERNANDEZ-RODRGUEZ E.. | 1 0.01 93.09 ANGELISON L, ALMER S, BAJOR A, BJORK .. | 1 0.01 93.10 ANTIMISIARIS M, SETTERS B. THE MEDS H.. | 1 0.01 93.11 ANTONELLA, B.. WORSENING OF OSTEONECR.. | 1 0.01 93.12 AOE M, ET AL.. A CASE OF PEMPHIGOID A.. | 1 0.01 93.13 AOKI Y, SATOH H, MATSUI Z, SAKURABAYA.. | 1 0.01 93.14 ARELLANO AL, MARTIN M, MONERRIS M, LL.. | 1 0.01 93.15 ARELLANO AL, MARTIN-SUBERO M, MONERRI.. | 1 0.01 93.16 ARELLANO AL, MARTIN-SUBERO M, MONERRI.. | 1 0.01 93.17 ARENAS MORALES AJ, SEEHERUNVONG W, AB.. | 1 0.01 93.18 ARSHAD M. ASCITES IN A PATIENTWITH GR.. | 1 0.01 93.19 ARSLAN F, TABAK F, AVSAR E, MIDILLI K.. | 1 0.01 93.20 ASHRAF, IMRAN; ROMANA, BHUPINDER; SOH.. | 1 0.01 93.21 ASTVAD K. FIRST DETECTION OF TR46/Y12.. | 1 0.01 93.22 ATANASKOVIC-MARKOVIC M, GAETA F, GAV.. | 1 0.01 93.23 ATEFI D, PINTO SANDER N, RICHARDSON D.. | 1 0.01 93.24 ATEFI D. ARE TESTICULAR MIXED GERM CE.. | 1 0.01 93.25 BABALOLA, O.. COMBINED BIOLOGIC THERA.. | 1 0.01 93.26 BAIRD P, LEUNG S, HOANG H, BABALOLA O.. | 1 0.01 93.27 BAKOTA E, ARNDT C, ROMOSER AA, WILSON.. | 1 0.01 93.28 BALAGONI H, DEVANI K, PHEMISTER J, YO.. | 1 0.01 93.29 BARIS VO, AKBULUT IM, OZCAN OU, KILIC.. | 1 0.01 93.30 BARTON J, WONG A, GRAUDINS A. ANTI-XA.. | 1 0.01 93.31 BAYRAM AK, CANPOLAT M, C?NAR SL, TAHA.. | 1 0.01 93.32 BECHTEL, A.. MULTIPLE UNUSUAL LUNG ET.. | 1 0.01 93.33 BEDNAREK R, EZRA N, TOUBIN Y, LINOS K.. | 1 0.01 93.34 BEN-AMI T. EWING SARCOMA: A 15-YEAR E.. | 1 0.01 93.35 BENIC, M.. CLINDAMYCIN-INDUCED NECROT.. | 1 0.01 93.36 BENNETT WM, BATIUK TD, MCEVOY KM, DOU.. | 1 0.01 93.37 BERGER C, FIORELLI M, STEINER T, SCHA.. | 1 0.01 93.38 BERRY AC, NAKSHABENDI R, KANAR O, JOH.. | 1 0.01 93.39 BHARADWAJ S, ALZAHRANI M, ALKHIARI R,.. | 1 0.01 93.40 BHATT HV, FROST EA. HYPOTENSION ON IN.. | 1 0.01 93.41 BHATTA M, LESBURG A. WEAK AT THE KNEE.. | 1 0.01 93.42 BIEBER, A.. SYSTEMIC METHOTREXATE FOR.. | 1 0.01 93.43 BINAGHI G; CONGIA D; COSSA S; MASSIDD.. | 1 0.01 93.44 BIONDANI P, BOUDJEMAI A, BLANCHET DE .. | 1 0.01 93.45 BISHOP-FREEMAN SC.POSTMORTEM METAXALO.. | 1 0.01 93.46 BJORKHOLM, M.. LONG-TERM TREATMENT OF.. | 1 0.01 93.47 BLACKWELL K, GASCON P, JONES CM, NIXO.. | 1 0.01 93.48 BLANCO A, GIGER-PABST U, SOLASS W, ZI.. | 2 0.02 93.50 BOKTOR M, MOTLIS A, ARAVANTAGI A, SHE.. | 5 0.05 93.55 BONFILS NA, BENYAMINA A, AUBIN H-J, L.. | 1 0.01 93.56 BORON E, MANOV N. AN UNUSUAL CASE OF .. | 1 0.01 93.57 BOSS MJ, DIAZ-GOMEZ JL, KOCH C. THE G.. | 1 0.01 93.58 BOTHA V, BHIKOO R, FRANZCO M. VENLAFA.. | 1 0.01 93.59 BRADBURY C, JENNER M, STRIHA A, COOK .. | 1 0.01 93.60 BRAINARD T. OBSTRUCTIVE SLEEP APNEA A.. | 1 0.01 93.61 BRANNSTROM M, JOHANNESSON L, BOKSTROM.. | 1 0.01 93.62 BRANNSTROM M, JOHANNESSON L, BOKSTROM.. | 1 0.01 93.63 BROENS A, COLLIGNON N.. MOXIFLAXIN AN.. | 1 0.01 93.64 BROIJL A, KERSTEN M, ALEMAYEHU W, LEV.. | 1 0.01 93.65 BRONSTEIN, A.. 2010 ANNUAL REPORT OF .. | 1 0.01 93.66 BROSNAN E, MODY K, ZUCKERMAN RA, RUOF.. | 1 0.01 93.67 BROWN GD, MUZYK AJ, PREUDHOMME XA. PR.. | 1 0.01 93.68 BROWN TM. A CASE OF SHOSHIN BERIBERI:.. | 1 0.01 93.69 BRUNO G, FABRIZIO C, MILANO E, DELL^A.. | 1 0.01 93.70 BUCHHOLZ S, DAMMANN E, STADLER M, KRA.. | 1 0.01 93.71 BURLANDO M,BURLANDO M. | 1 0.01 93.72 BUTTAR RS, BATRA J, KREIMERMAN J, ALE.. | 1 0.01 93.73 BUTTAR RS, KREIMERMAN J, ALETA M, MEL.. | 1 0.01 93.74 BUTTAR, R.. RHABDOMYOLYSIS AND AKI WI.. | 1 0.01 93.75 BYERLY LK, YUKAWA M. SEIZURES OR SADN.. | 1 0.01 93.76 C. PRIEZ-BARALLON. QUANTIFICATION OF .. | 1 0.01 93.77 CAMPIONE E, DI PRETE M, DEL PRINCIPE .. | 1 0.01 93.78 CANEL L, ZISIMOPOULOU S, BESSON M, NE.. | 1 0.01 93.79 CANO-MOLLINEDO M, RODRIGUEZ DEL RIO P.. | 1 0.01 93.80 CAPPELLA M,PUGLIESE F,ZUCCHINI A,MARC.. | 1 0.01 93.81 CARLE, G.. CORTICOTHERAPY AND SUICIDA.. | 1 0.01 93.82 CARLOS MARI?O VIGOA, GORKY MORI PINED.. | 1 0.01 93.83 CARLOS MARI?O VIGOA,*, GORKY MORI PIN.. | 1 0.01 93.84 CARLOS MARI?O VIGOA,*, GORKY MORI PIN.. | 1 0.01 93.85 CARRENO E, RODRIGUEZ J, MARTINEZ S, D.. | 1 0.01 93.86 CARRENO ER, RODRIGUEZ JAM, MARTINEZ S.. | 1 0.01 93.87 CARROLL B, GOLDHABER S, LIU P AND PIA.. | 1 0.01 93.88 CARROLL B, GOLDHABER S, LIU P AND PIA.. | 1 0.01 93.89 CETIN O, AYDOA, B, ULUDA S, FIEN C, C.. | 1 0.01 93.90 CEYLAN D, KACAR M, ULAS H. MANIC EPIS.. | 1 0.01 93.91 CHAHLA E, CHEESMAN A, HAMMAMI M, TAYL.. | 1 0.01 93.92 CHATZOPOULOU, M. A CASE OF FATAL SEPS.. | 1 0.01 93.93 CHEHL N, ALMADANI B, JAKATE S, KESHAV.. | 1 0.01 93.94 CHEN J, KONG X, SUN X. EFFECT OF SELE.. | 1 0.01 93.95 CHEN T, MOON K, DEMELLO DE, FEIZ-ERFA.. | 1 0.01 93.96 CHENOWETH J, COLBY D, SUTTER M, RADKE.. | 1 0.01 93.97 CHENOWETH JA, COLBY DK, SUTTER ME, RA.. | 1 0.01 93.98 CHEW AP , LIM WS, TAN KT. DONEPEZIL-I.. | 1 0.01 93.99 CHIBA M, AIZAWA N, ASAI R, KUHO N, SA.. | 1 0.01 94.00 CHISHOLM JC, MERKS JH, CASANOVA M, BI.. | 1 0.01 94.01 CHOI MS, JEON H, KIM HS, JANG BH, LEE.. | 1 0.01 94.02 CHRISTIAN, M.. USE OF CONTINUOUS VENO.. | 1 0.01 94.03 CIBICKOVA, LUBICA. MULTI-DRUG INTOXIC.. | 1 0.01 94.04 CIMINO C, CHARNESKI L, KUMAR L. IDIOS.. | 1 0.01 94.05 CLOWSE, M.. PREGNANCY OUTCOMES IN THE.. | 1 0.01 94.06 COLOVIC, N.. ACUTE MYOCARDIAL INFARCT.. | 1 0.01 94.07 COMER, R.. MEDICATION REVIEW AND TRAN.. | 1 0.01 94.08 CONTEDUCA V, CAFFO O, DEROSA L, VE.. | 1 0.01 94.09 CONTEDUCA V, CAFFO O, DEROSA L, VECC.. | 1 0.01 94.10 CONTEDUCA V, CAFFO O, DEROSA L, VECCI.. | 1 0.01 94.11 CONTEDUCA V, CAFFO O, DEROSA L, VECCI.. | 1 0.01 94.12 CONTEDUCA V, CAFFO O, DEROSA L, VECCI.. | 1 0.01 94.13 COSCI F. WITHDRAWAL SYMPTOMS AS A CON.. | 1 0.01 94.14 COSSEY M, HSU A, SEGUIAS L. 8-YEAR-OL.. | 1 0.01 94.15 CUNY P, HOUOT M, GINISTY S, HOROWICZ .. | 1 0.01 94.16 CUNY P, HOUOT M, GINISTY S, HOROWICZ .. | 1 0.01 94.17 DAISUKE YUKI (MD), YUJI OKURA, TSUGUM.. | 1 0.01 94.18 DANIEL A. UNDERSTANDING OF ANTIEPILEP.. | 1 0.01 94.19 DASHWOOD A, MASON R, JENNINGS C, DHIL.. | 1 0.01 94.20 DE CRUZ R, FERGUSON J, WEE JS, AKHRAS.. | 1 0.01 94.21 DEJOU-BOUILLET L, BOURDEL N, SLIM K, .. | 1 0.01 94.22 DELGADO MG, CORTE JR, S?IZ A, CALLEJA.. | 1 0.01 94.23 DELGADO MG, CORTE JR, SAIZ A, CALLEJA.. | 1 0.01 94.24 DESCOEUR J, PHILIBERT L, CHALARD K, E.. | 1 0.01 94.25 DIAZ GUTIERREZ MJ. BENZODIAZEPINES IN.. | 1 0.01 94.26 DICHEVA, S.. 2017;204-9 | 1 0.01 94.27 DIENER H, ESCHENFELDER C, GROND M, KE.. | 1 0.01 94.28 DIENER H, KERMER P, ESCHENFELDER C, G.. | 1 0.01 94.29 DOBERSTEIN T, KAUR A, FIELD E, SINGH .. | 1 0.01 94.30 DOPAMINE AGONIST WITHDRAWAL SYNDROME .. | 1 0.01 94.31 DUNN, L.. A PHASE II STUDY OF TEMSIRO.. | 2 0.02 94.33 EBISUI C., HAMANO R., NUSHIJIMA Y., Y.. | 1 0.01 94.34 EFFERTH T, SCHOTTLER U, KRISHNA S, SC.. | 1 0.01 94.35 EFFERTH T, SCHOTTLER U, KRISHNA S, SC.. | 1 0.01 94.36 EGGLESTON W, CLARK KH, MARRAFFA JM. L.. | 1 0.01 94.37 EMA. FLUOROQUINOLONES FOR SYSTEMIC AN.. | 1 0.01 94.38 ESHO MA, KURMAYAGARI KA. BOERHAAVE^S .. | 1 0.01 94.39 EVERAGE N, PRADA C, LIU S, BALASHOV K.. | 1 0.01 94.40 EVRENSEL, A.. PSYCHOTIC AND DEPRESSIV.. | 1 0.01 94.41 F A. DIMETHYL FUMARATE IN A PATIENT W.. | 1 0.01 94.42 FAIZ A, BHATTI H, ALI SK. A HOLE-Y CA.. | 1 0.01 94.43 FANOUS, A.. LIFE-THREATENING MANNITOL.. | 1 0.01 94.44 FEJZO MS, MACGIBBON KW, MULLIN PM. ON.. | 3 0.03 94.47 FINK A, BAHLO J, ROBERCHT S, AL-SAWAF.. | 1 0.01 94.48 FIROZ T, WEBBER D, ROWE H. DRUG-INDUC.. | 1 0.01 94.49 FLOISAND, Y.. TARGETING INTEGRIN ?4?7.. | 1 0.01 94.50 FONTANA RJ, ENGLE RE, SCAGLIONE S, AR.. | 1 0.01 94.51 FORUNY J, BLAZQUEZ J, MORENO A, BARCE.. | 1 0.01 94.52 FOSTER KA, ARES WJ, POLLACK IF, JAKAC.. | 1 0.01 94.53 FRANCESCANGELI, J.. PERIOPERATIVE DIA.. | 1 0.01 94.54 FRANCOIS L, CHARLES-NELSON A, FAIN O,.. | 1 0.01 94.55 FRANZ, C.. POTENTIAL DRUG-DRUG INTERA.. | 1 0.01 94.56 FROST J., LOKKEN T.N., HELLAND A., NO.. | 1 0.01 94.57 FUJII K, ET AL. A CASE OF ABNORMAL TH.. | 1 0.01 94.58 FUKUSHI J. USE EXPERIENCE OF GOLIMUMA.. | 1 0.01 94.59 FUKUSHIMA M, INOUE S, INOKUMA T.. CLI.. | 1 0.01 94.60 FULLER W, RAGSDALE J. THE GRAVITY OF .. | 1 0.01 94.61 FUX C., FEHR T. NEPHROLOGY. 1ST SWISS.. | 1 0.01 94.62 G?ZA S. IDARACIZUMAB ALKALMAZASA DABI.. | 1 0.01 94.63 GAINES A, CRONIN L, HAMEL M. AN UNUSU.. | 1 0.01 94.64 GAINES A, CRONIN L, HAMEL M.. AN UNUS.. | 1 0.01 94.65 GANIGARA A, RAVISHANKAR C, RAMAVAKODA.. | 1 0.01 94.66 GARCIA-RODIGUEZ JA, PATTULLO A. IDIOP.. | 1 0.01 94.67 GARG J, ARONOW WS, DEVABHAKTUNI S, AH.. | 1 0.01 94.68 GARG S.K, SINGH O, DEEPAK D, SINGH A,.. | 1 0.01 94.69 GASS-JEGU, F. GASTROINTESTINAL PERFOR.. | 1 0.01 94.70 GEMET L, PARA M, SADEGHI N. USE OF N-.. | 1 0.01 94.71 GESSERT D, LENHART A, KOTHARI VK, YES.. | 1 0.01 94.72 GETRAJDMAN, J.. CASE OF MATERNAL AND .. | 1 0.01 94.73 GHIMIRE KB, NEPAL B. DYSPNEA AFTER TR.. | 1 0.01 94.74 GHOLKAR, G.. THE HYBRID CHANNELOPATHY.. | 1 0.01 94.75 GIRALDI E. RISK-ADAPTED TREATMENT FOR.. | 1 0.01 94.76 GIRALDI, E.. RISK-ADAPTED TREATMENT F.. | 1 0.01 94.77 GIRISHA M K, KODANDAPANIA S, SHETTYA .. | 1 0.01 94.78 GLADMAN, D.. TOFACITINIB FOR PSORIATI.. | 2 0.02 94.80 GLOGHINI A. MET-DRIVEN RESISTANCE TO .. | 1 0.01 94.81 GLUECK CJ, FRIEDMAN J, HAFEEZ A, HASS.. | 1 0.01 94.82 GODFREY M, FINN A, ZAINAH H, DAPAAH-A.. | 1 0.01 94.83 GOLDBERGER DJ, VEARRIER D. INHALATION.. | 1 0.01 94.84 GOLOMB, B.. FLUOROQUINOLONE-INDUCED S.. | 1 0.01 94.85 GOODBAR NH, FOUSHEE JA, NASH K, CONNO.. | 1 0.01 94.86 GOODCHILD JH, DONALDSON M. A CLINICAL.. | 1 0.01 94.87 GUMBREVICIUS G, SVEIKATA A. A CASE OF.. | 1 0.01 94.88 HAGELBERG N. M. ET AL.. INTERACTION O.. | 1 0.01 94.89 HALL J, HUGHES C, FOISY M, SHAFRAN S,.. | 1 0.01 94.90 HAMMERSTROM AE. POSSIBLE AMLODIPINE-I.. | 1 0.01 94.91 HANSEN P, THOMSEN R, ZAKARIAN K AND H.. | 1 0.01 94.92 HARKOUK H, DE PREVILLE G, BENHAMOU D... | 1 0.01 94.93 HAROON, N.. HYPOMAGNESEMIA AND CHEMOT.. | 1 0.01 94.94 HASEGAWA C, KUDO M, MARUYAMA H, KIMUR.. | 1 0.01 94.95 HASSAN SA, AMER S, QURESHI W, ALIRHAY.. | 1 0.01 94.96 HATCH, D.. REFRACTORY STATUS EPILEPTI.. | 1 0.01 94.97 HATTORI H, TSUCHIMOCHI T, HANADA Y, A.. | 1 0.01 94.98 HAYAKAWA K, MIZUTANI J, SUZUKI N, HAA.. | 1 0.01 94.99 HAYASHI Y, NAGAHARA A, KAWASHIMA A, K.. | 1 0.01 95.00 HAZAN E, SANTA E, SAHU J. DIFFUSE RAS.. | 1 0.01 95.01 HAZAN, E.. DIFFUSE RASH AFTER THE ADM.. | 1 0.01 95.02 HEARD K, RUMACK BH, GREEN JL, BUCHER-.. | 2 0.02 95.04 HEATHMAN JC, NEAL DW, THOMAS CR. SLEE.. | 1 0.01 95.05 HEISE C, SKOLNIK A, RASCHKE R, OWEN-R.. | 2 0.02 95.07 HEISE CW, GRAEME KA, BOSAK AR. MASSIV.. | 1 0.01 95.08 HELBIG, G.. IRREVERSIBLE MARROW APLAS.. | 1 0.01 95.09 HENAO M, GHAFFARI G. ANAPHYLAXIS TO P.. | 1 0.01 95.10 HENDARSIH E, FADJARI TH, OEHADIAN A... | 1 0.01 95.11 HENDARSIH E, FADJARI TH, OEHADIAN A. .. | 1 0.01 95.12 HIGGS J, BRADEN G. HARD PRESED TO STO.. | 1 0.01 95.13 HILL SE, KIRSTEN L. TRIPTAN-INDUCED T.. | 1 0.01 95.14 HIRASE M, SETO M, KOGA S, SUEMATSU R,.. | 1 0.01 95.15 HIROHASHI Y, SHINOZAKI Y, TANAKA M, S.. | 1 0.01 95.16 HOASHI T, HIRABAYASHI M, NAKAJIMA R, .. | 1 0.01 95.17 HOCHHAUS A, SAUSSELE S, BAERLOCHER G,.. | 1 0.01 95.18 HOFER S, PHILIPSENBURG C, WEIGAND M, .. | 1 0.01 95.19 HONG CR, KANG HJ, KIM HS, JU HY, LEE .. | 2 0.02 95.21 HSIAO, S.. RHABDOMYOLYSIS CAUSED BY T.. | 1 0.01 95.22 HUANG SS, XENOCOSTAS A, MOIST LM, CRO.. | 1 0.01 95.23 HULS G, CHITU D, HAVELANGE V, JONGEN-.. | 1 0.01 95.24 HUMAYUN Y, SANCHEZ P, NORRIS L T, MON.. | 1 0.01 95.25 HUNG SW. MINOCYCLINE-INDUCED ACUTE EO.. | 1 0.01 95.26 HUSNAIN M, GONDAL F, RAINA AI, RIAZ I.. | 1 0.01 95.27 HUSSAIN S, JHAJ R, AHSAN S, AHSAN M, .. | 1 0.01 95.28 IHORST G, UDI J, KOCH B, WAESCH R, EN.. | 1 0.01 95.29 IIDA J. C-06 A PATIENT WITH TYPE 2 DI.. | 1 0.01 95.30 IMAMURA T, URATA T, KOBAYASHI M, GEN .. | 1 0.01 95.31 IMRAN M, SHAFI H, MAHMOOD Z, SARWAR M.. | 1 0.01 95.32 INCECIK F, HERGUNER OM, BESEN S ACUTE.. | 1 0.01 95.33 INCECIK F, HERGUNER OM, BESEN S, ALTU.. | 1 0.01 95.34 ISHIHARA H, OKUMI M, UNAGAMI K, HIRAI.. | 2 0.02 95.36 ISHIZONE S, ET AL. FATAL INTERSTITIAL.. | 1 0.01 95.37 ISLAM S, SINGER M, KULHANJIAN JA. TOX.. | 1 0.01 95.38 ITO M, Y, UMEZAWA Y, NAKAGAWA H. A CA.. | 1 0.01 95.39 ITOU K.. 2015;118(4):500. | 1 0.01 95.40 IWANISHI T, YUMIBA S, KOIDA Y, KOBAYA.. | 1 0.01 95.41 J L,MOSTER M,BHATT M. SSRI-ASSOCIATED.. | 1 0.01 95.42 JA D,JL M,T S,MP W,AIM H,JE A. PROGRE.. | 1 0.01 95.43 JAAFARI M, BOUT A, RAMMOUZ I, AALOUAN.. | 1 0.01 95.44 JACOBS TP, KAUFMAN M, JONES G, KUMAR .. | 1 0.01 95.45 JAEKEL N, HUBERT K, KRAHL R, HAENEL M.. | 1 0.01 95.46 JAKEMAN B, CONKLIN J, BOUCHONVILLE M,.. | 1 0.01 95.47 JANAKIRAM M. ACCELERATED LEUKEMIC TRA.. | 1 0.01 95.48 JAYARANGAIAH, A.. EARLY RECOGNITION I.. | 1 0.01 95.49 JI D, CAO J, HONG X, GUO Y. THE INCID.. | 1 0.01 95.50 JOSEPHSON MA, PERAZELLA MA, CHOI MJ. .. | 2 0.02 95.52 JOURNAL CASE REPORT: A CASE OF DRUG-I.. | 1 0.01 95.53 JOVANOVIC M, SHAHID T, DHARMARAJAN TS.. | 1 0.01 95.54 JULLIAN-DESAYES I, ROSELLI A, LAMY C,.. | 1 0.01 95.55 JUNICHI H, ET AL. TWO CASES OF TREATM.. | 1 0.01 95.56 KAGAL DR, CRYSTAL E, LASHEVSKY I, TIO.. | 1 0.01 95.57 KAGSTROM S, LEANDERSSON A, FORSBERG L.. | 1 0.01 95.58 KAGSTROM S, LEANDERSSON A, FORSBERG L.. | 1 0.01 95.59 KAKU Y, KODAMA S, HIGUCHI M, NAKAMURA.. | 1 0.01 95.60 KANEDA H. GASTROINTESTINAL PERFORATIO.. | 1 0.01 95.61 KANEKO T, KANEKO M. A PATIENT WITH CY.. | 1 0.01 95.62 KANEKO, K.. A SUCCESSFUL RESPONSE AFT.. | 1 0.01 95.63 KANIEWSKA AM, RYDZEWSKA G. EFFICACY A.. | 1 0.01 95.64 KANTARJIAN, H.. HEPATIC ADVERSE EVENT.. | 1 0.01 95.65 KAO JC, LIAO B, MARKOVIC SN, KLEIN CJ.. | 1 0.01 95.66 KAPOOR KG. REGARDING SECONDARY INTRAC.. | 1 0.01 95.67 KAPOOR M, GREENOUGH G. SPECTRUM OF SL.. | 1 0.01 95.68 KARVUNIDIS T, HARAZIM M, RADEJ J, NOV.. | 1 0.01 95.69 KARVUNIDIS T, HARAZIM M, RADEJ J, NOV.. | 1 0.01 95.70 KARVUNIDIS T, HARAZIM M, RADEJ J, NOV.. | 1 0.01 95.71 KATONA BW, ROCCARO GA, SOULEN MC, YAN.. | 1 0.01 95.72 KATSUYAMA T, SADA K, YAN M, ZEGGAR S,.. | 1 0.01 95.73 KAWANO, S. A CASE OF ILEAL PERFORATIO.. | 1 0.01 95.74 KAWASATO R, HASHIMOTO S, SHIRASAWA T,.. | 1 0.01 95.75 KAYA S, AY N, BAYSAL B, COMOGLU S. P-.. | 1 0.01 95.76 KAZUMA N, TAKESHI M, TAKAHISA K, KOJI.. | 1 0.01 95.77 KEIGO YASUMASA, ET AL.,TWO CASES OF C.. | 1 0.01 95.78 KENMUIR C , RICHARDSON M , GHEARING G.. | 1 0.01 95.79 KERMER P, ESCHENFELDER C, DIENER H. R.. | 1 0.01 95.80 KERN C., FLEYSHMAN R., BOYLE S.. METH.. | 1 0.01 95.81 KHELOUFI F, DEFAULT A, PERROUTY B, BL.. | 1 0.01 95.82 KIBA, T.. A PANCREATIC CANCER PATIENT.. | 1 0.01 95.83 KIDO K, WHEELER MB, SERATNAHAEI A, BA.. | 1 0.01 95.84 KIKUCHI S, OKADA S, KUBOTA T, MIURA M.. | 1 0.01 95.85 KIMURA Y, FUJII M, MASUISHI T, NISHIK.. | 1 0.01 95.86 KING G, BYRNE A, FLEMING P. A CASE OF.. | 1 0.01 95.87 KINZEL, O.. TOXIC CEREBELLAR SYNDROME.. | 1 0.01 95.88 KITAGAWA M, YAMANAKA Y, ADACHI T, ITO.. | 1 0.01 95.89 KITANO K, GIBO Y, KAMIJO A, FURUTA K,.. | 1 0.01 95.90 KITCHLOO K, GORUKANTI PK, KHANIJAO S,.. | 1 0.01 95.91 KLAAS JP, MATZKE T, MAKOL A, FULGHAM .. | 1 0.01 95.92 KNOLL, G.. MYCOPHENOLATE MOFETIL DOSE.. | 1 0.01 95.93 KNOP S, LANGER C, ENGELHARDT M, STUEB.. | 1 0.01 95.94 KOBASHI H, ISHIMOTO S, ISHII S, YAKUS.. | 1 0.01 95.95 KOBAYASHI N.. A CASE OF PROTEIN-LOSIN.. | 1 0.01 95.96 KOCH HJ. SEVERE QUETIAPINE WITHDRAWAL.. | 1 0.01 95.97 KODAKA R, YAGO K, YAYAMA K, HASHIGUCH.. | 1 0.01 95.98 KODALI S, BATHINI V, RAVA P, TIPIRNEN.. | 1 0.01 95.99 KOLLI V, MARY H, GARCIA-DELGAR B, COF.. | 1 0.01 96.00 KOLLI V, MARY H, GARCIA-DELGAR B, COF.. | 1 0.01 96.01 KOLLI V,MARY H,GARCIA-DELGAR B,COFFEY.. | 1 0.01 96.02 KOLLI, V.. QUETIAPINE ADDICTION IN AN.. | 1 0.01 96.03 KOMEI ISHIKAWA ET.AL. A CASE OF ARIPI.. | 1 0.01 96.04 KUBOTA M, HAMASAKI Y, YOSHIDA Y, TAKA.. | 1 0.01 96.05 KUDO, K.. A FATAL CASE OF POISONING R.. | 1 0.01 96.06 KUO YR, CHEN CC, CHEN YC, YEH MC, LIN.. | 1 0.01 96.07 KUROKAWA M, NAITO S, ICHIYANAGI O, KA.. | 1 0.01 96.08 KURTZHALTS, K.. EVIDENCE OF A CLINICA.. | 1 0.01 96.09 KUSKONMAZ, S. A CASE OF CHRONIC LYMPH.. | 1 0.01 96.10 KUSTERMANN A, MOBIUS C, OBERSTEIN T, .. | 1 0.01 96.11 L. BERNAL, B. ESTEVEZ. CORNEAL TOXICI.. | 1 0.01 96.12 LABAN E, HAINAUT-WIERZBICKA E, POURRE.. | 1 0.01 96.13 LADWA, R.. POSTERIOR REVERSIBLE ENCEP.. | 1 0.01 96.14 LAES J, OLINGER C, COLE J. USE OF PER.. | 1 0.01 96.15 LAES J, OROZCO BS, COLE JB. USE OF PE.. | 1 0.01 96.16 LAES J, OROZCO BS, COLE JB. USE OF PE.. | 1 0.01 96.17 LAES J,OLINGER C,COLE J. USE OF PERCU.. | 1 0.01 96.18 LAES J,OLINGER C,COLE J. USE OF PERCU.. | 1 0.01 96.19 LAES JR, OLINGER C, COLE JB. USE OF P.. | 1 0.01 96.20 LAES JR, OLINGER C, COLE JB. USE OF P.. | 1 0.01 96.21 LAINE A. 18TH BIENNIAL WORL CONFERENC.. | 1 0.01 96.22 LECA. HIGHER LEVELS OF LEFLUNOMIDE AR.. | 1 0.01 96.23 LEE AR, SHARMA S, MAHMOUD TH. TUBULOI.. | 1 0.01 96.24 LEE CY, SUZUKI JB.. MEDICATION-RELATE.. | 1 0.01 96.25 LEGENDRE T, BOUDEBESSE C, HENRY C, ET.. | 1 0.01 96.26 LEIGHL N, TSAO M, HO C, SHEPHERD F, M.. | 1 0.01 96.27 LI W, ZHOU Y, LI Q, TONG H, LU W. INT.. | 2 0.02 96.29 LI, W.. INTESTINAL PERFORATION DURING.. | 2 0.02 96.31 LINQIU Z, PENGCHENG L. SEVERE GI COMP.. | 1 0.01 96.32 LITERARY CITATION: FUKUDA, Y., FUJIO,.. | 1 0.01 96.33 LITERATURE REFERENCE: CANTRELL FL, MA.. | 1 0.01 96.34 LOCKHART, N.. ITRACONAZOLE THERAPY IN.. | 1 0.01 96.35 LONATI, D.. PERIDURAL ACCIDENTAL ADMI.. | 1 0.01 96.36 LOOMBA RS, SINGH AK, KOVACH J, GUDAUS.. | 1 0.01 96.37 LOPES LM, CARRILHO MC, FRANCISCO RPV,.. | 1 0.01 96.38 LOPEZ PARDO, P.. MYOCLONUS DUE TO FEN.. | 1 0.01 96.39 LU H, MARENGO MF, MIHU CN, MANERO GG,.. | 1 0.01 96.40 LU, B.. FACIAL MANIFESTATIONS OF EPST.. | 2 0.02 96.42 LUCIRE, Y.. ANTIDEPRESSANT-INDUCED AK.. | 2 0.02 96.44 LUCYK SN, YAREMA MC, SIVILOTTI ML, JO.. | 1 0.01 96.45 LUKAS C, BELLENBERG B, HOEPNER R, ELL.. | 1 0.01 96.46 LUYASU S, GONZALEZ M, DIVE A. HIGH AN.. | 1 0.01 96.47 M BURLANDO. BILATERAL WARTHIN TUMOR I.. | 1 0.01 96.48 M TURAN OZHAN, DRISCOL C, CETIN-DEMIR.. | 1 0.01 96.49 MACIULAITYTE I, KORSAKIENE Z, BLAZIEN.. | 1 0.01 96.50 MACLEOD-GLOVER N, MINK M, YAREMA M, C.. | 1 0.01 96.51 MAGRO CM, TOLEDO-GARCIA A, PALA O, MO.. | 1 0.01 96.52 MAHER DP, KISSEN M, DANOVITCH I, YUMU.. | 1 0.01 96.53 MAHFOOD HADDAD T, NAWAZ MS, ABUZAID A.. | 1 0.01 96.54 MAKINO T. CURRENT STATUS OF CABAZITAX.. | 1 0.01 96.55 MALKHASYAN K, HALENE S, LACY J. OXALI.. | 1 0.01 96.56 MANCANO, M.. ISMP ADVERSE DRUG REACTI.. | 1 0.01 96.57 MANCANO, M.. ISMP ADVERSE DRUG REACTI.. | 1 0.01 96.58 MARCHEI E, PALMI I, PICHINI S, PACIFI.. | 1 0.01 96.59 MARCHEI E, PALMI I, PICHINI S, PACIFI.. | 1 0.01 96.60 MARRAZZO G, CRUZ JR P. IMMEDIATE TYPE.. | 1 0.01 96.61 MARTIN P. A PHASE II TRIAL OF LENALID.. | 1 0.01 96.62 MARTIN-SUBERO M, MONERRIS M, LLERENA .. | 1 0.01 96.63 MARTINEZ LOPEZ, A.. IBUPROFEN-INDUCED.. | 3 0.03 96.66 MARZOLINI C. DRUG DRUG INTERACTION IN.. | 1 0.01 96.67 MASAGO T, KAWAMOTO B, HIKITA K, TAKEN.. | 1 0.01 96.68 MASON P, PERDIGONES N, MORALES M, BES.. | 1 0.01 96.69 MASSIMO OFFIDANIA, LAURA CORVATTAA, A.. | 1 0.01 96.70 MATHAI E, ROLAIN JM, VERGHESE L ET AL.. | 1 0.01 96.71 MATSUI A. EVALUATION OF EFFICACY AND .. | 1 0.01 96.72 MATSUO M, SANO I, IKEDA Y, FUJIHARA E.. | 1 0.01 96.73 MATSUURA, T.. A CASE OF SEVERE CYTOPE.. | 1 0.01 96.74 MAWRI, S.. VANCOMYCIN-INDUCED ACUTE G.. | 1 0.01 96.75 MAYA Y, FUJITA Y, NAKAYAMA C, ET AL. .. | 1 0.01 96.76 MEASE, P.. TOFACITINIB OR ADALIMUMAB .. | 1 0.01 96.77 MEENA M, GUPTA N, KEWLANI J, KUMARARE.. | 1 0.01 96.78 MEENAKSHI SUNDARAM S, SWAMINATHAN K, .. | 1 0.01 96.79 MEIJDEN EVD, HORVATH B, NIJLAND M, DE.. | 1 0.01 96.80 MERCANTI SD, DURELLI L, IUDICELLO M, .. | 1 0.01 96.81 MICELI MH, GONULALAN M, PERRI MB, SAM.. | 1 0.01 96.82 MISRA DP, EDAVALATH S, CHOWDHURY AC, .. | 1 0.01 96.83 MISRA DP, EDAVALATH S, CHOWDHURY AC, .. | 1 0.01 96.84 MIURA N, NISHIDA K, ARAI O, WATANABE .. | 1 0.01 96.85 MIYASHITA Y. ^A CASE OF ADVANCED BREA.. | 1 0.01 96.86 MIYAZAKI Y. A CASE OF PATIENT PRESENT.. | 1 0.01 96.87 MIZUNO T. A CASE OF ECTHYMA DURING TH.. | 1 0.01 96.88 MIZUSHIMA I, AIZU M, MIZUSHIMA I, NAK.. | 1 0.01 96.89 MJELLE AB, DONNER EM, BERG A. A CHILD.. | 1 0.01 96.90 MOHAMMED, R.. ALTERED MENTAL STATUS C.. | 1 0.01 96.91 MOHAPATRA S. SUCCESSFUL MANAGEMENT OF.. | 1 0.01 96.92 MOJADIDI. M.. AN UNUSUAL PRESENTATION.. | 1 0.01 96.93 MOJKOWSKA A, WYLEZOL M, FRACZEK M, BA.. | 1 0.01 96.94 MOMOKI T, SATO T, GUUJI M, TERAUCHI Y.. | 1 0.01 96.95 MONTE, AA, BODMER M, AND SCHAEFFER TH.. | 1 0.01 96.96 MOREAU B, CLEMENT P, THEORET Y, SEIDM.. | 2 0.02 96.98 MORI F, BARNI S, MANFREDI M, PECORARI.. | 1 0.01 96.99 MORICI N; PERNA E; CIPRIANI M; OLIVA .. | 1 0.01 97.00 MORTON J, NELLURI S. USE OF A THROMBE.. | 1 0.01 97.01 MOTTA I, CALCAGNO A, BAIETTO L, D^AVO.. | 1 0.01 97.02 MOTTA, I.. A PROBABLE DRUG-TO-DRUG IN.. | 1 0.01 97.03 MOURGUET M, JEANNEL J, LAFFONT MA, .. | 1 0.01 97.04 MOWRY J, SPYKER D, CANTILENA JR L, MC.. | 1 0.01 97.05 MUELLER B, SALCHOW D, WAFFENSCHMIDT E.. | 1 0.01 97.06 MULLER, S.. INTRALIPID EMULSION RESCU.. | 1 0.01 97.07 MUNOZ JL, KESSLER AA, FELIG P, CURTIS.. | 1 0.01 97.08 MURIE J, AGARWAL M. SUB-ACUTE CUTANEO.. | 1 0.01 97.09 MURPHY C, BEUHLER MC, HART G, CHUANG .. | 1 0.01 97.10 MW S. BENEFIT OF URIDINE TRIACETATE (.. | 1 0.01 97.11 NAEGELI E, IMOBERDORF R, KUSS F, J?GG.. | 1 0.01 97.12 NAG S, WEINSTEIN M, GREENBERG S. 14-Y.. | 1 0.01 97.13 NAG, D.. PERIANESTHETIC REFRACTORY AN.. | 1 0.01 97.14 NAGAI M, SAKATA N, UEDA S, OKANO M, U.. | 1 0.01 97.15 NAKADE K, MIZUMOTO Y, NAKADE K, OBATA.. | 1 0.01 97.16 NAKAMURA H. EXPERIENCE OF USING IMMUN.. | 1 0.01 97.17 NAKAMURA K. A CASE OF DRUG-INDUCED CA.. | 1 0.01 97.18 NAKANISHI N, ET AL.. A CASE OF PLETHO.. | 1 0.01 97.19 NAKANO Y, NAKANO Y, OHASHI A, KANEHIS.. | 1 0.01 97.20 NAKAOKA S. A CASE OF PREMATURE BABY W.. | 1 0.01 97.21 NAKAYA A. REALISTIC LENALIDOMIDE DOSE.. | 1 0.01 97.22 NAKAYA A. REALISTIC LENALIDOMIDE DOSE.. | 1 0.01 97.23 NAKHARANIYOM T, JIRAWATTANAPHAISAN T,.. | 1 0.01 97.24 NAM, S.. XANTHOGRANULOMATOUS APPENDIC.. | 1 0.01 97.25 NAOTO TAKAHASHI, CHIAKI NAKASEKO, KAI.. | 1 0.01 97.26 NARUMIYA H, NARUMIYA H, YAMADA H AND .. | 1 0.01 97.27 NESHIGE S, KANAYA Y, TAKESHIMA S, YOS.. | 1 0.01 97.28 NEUROLEPTIC MALIGNANT SYNDROME, INTER.. | 2 0.02 97.30 NICHOLAS E,THORNTON M. LIDOCAINE TOXI.. | 1 0.01 97.31 NISHII, T; UCHIMA Y, YAMAKOSHI Y, EN .. | 1 0.01 97.32 NISHIKAWA K, TAKEDA S, KOIKE M, IWATA.. | 1 0.01 97.33 NIXON CP, CHEVES TA, SWEENEY JD. SULF.. | 1 0.01 97.34 NORDSTROM, K.. PSYCHIATRIC EMERGENCIE.. | 1 0.01 97.35 ODA F. SHIRAISHI K, YATSUKA K, ET AL;.. | 1 0.01 97.36 ODEN. THE FREEDOM TO BIRTH-THE USE OF.. | 1 0.01 97.37 OGBATA S, JAMY O, RAJAN S, GOSMANOVA .. | 1 0.01 97.38 OHTA H, SATO N, KAWAMURA Y, HASEBE N... | 1 0.01 97.39 OKAMOTO N, IIDA T, SUGISAWA C, TAKAHA.. | 1 0.01 97.40 OKORONKWO SM, MEHR A. A SLEEPING GIAN.. | 1 0.01 97.41 OMAR A, ELLEN R, SORISKY A. METFORMIN.. | 1 0.01 97.42 OMI T, KANAI K, KIGUCHI T, NISHIDA T,.. | 1 0.01 97.43 ONAKA T, TAKAHASHI N, MIURA M, YONEZA.. | 1 0.01 97.44 ONO Y., TAKEUCHI S., AND NAGAI K., ET.. | 1 0.01 97.45 ORLIAGUET G, HAMZA J, COULOIGNER V, D.. | 1 0.01 97.46 ORTON S.; CENSANI M. IATROGENIC CUSHI.. | 1 0.01 97.47 OSAWA Y, GOZAWA R, KOYAMA K, NAKAYAMA.. | 1 0.01 97.48 OZALP DT, KACAR M, ULAS H. MANIC EPIS.. | 1 0.01 97.49 OZGULER Y, HAMURYUDAN V, HATEMI G, UG.. | 1 0.01 97.50 PAINHAS T, AMORIM M, SOARES R, DUARTE.. | 1 0.01 97.51 PAINHAS, T.. IDIOPATHIC INTRACRANIAL .. | 1 0.01 97.52 PALMIERE C, AUGSBURGER M, DEL MAR LE.. | 1 0.01 97.53 PANNY M, TROPPAN K, NEUMEISTER P, NOS.. | 1 0.01 97.54 PAOLINI J, GALLEGO S, BERNAL P, MARTI.. | 1 0.01 97.55 PAOLUCCI S, PREMOLI M, GULMINETTI R, .. | 1 0.01 97.56 PAPASTATHOPOULOS K, BOUZAS E, NAOUM G.. | 1 0.01 97.57 PARK J, HWANG SR, WOO SH, YUN SK, KIM.. | 1 0.01 97.58 PARK M, NGUYEN V, DEBORD J. A TWIST O.. | 1 0.01 97.59 PARK M, PAYNE B, ALONSO A. WHAT^S UP,.. | 1 0.01 97.60 PARKER G. DEVELOPMENT OF AN INCIPIENT.. | 1 0.01 97.61 PATEL V, KRISHNA AS, LEFEVRE C, KAAG.. | 1 0.01 97.62 PENKERT H, DELBRIDGE C, WANTIA N, ET .. | 1 0.01 97.63 PEREL-WINKLER A, BELOKOVSKAYA R, AMIG.. | 1 0.01 97.64 PETROS V, MASLONKA M, AZIZ N, SEDRAK .. | 1 0.01 97.65 PETTIT NN, PISANO J, WEBER S, RIDGWAY.. | 1 0.01 97.66 PIKIJA S, SZTRIHA L, MUTZENBACH S, GO.. | 1 0.01 97.67 PINKHASOV A, FURER T, AUGUSTO S. TRAN.. | 1 0.01 97.68 PINNIX C, ANDRAOS T, DABAJA B, MILGRO.. | 1 0.01 97.69 PINTO V, BALOCCO M, QUINTINO S, AMBAG.. | 1 0.01 97.70 PISZCZEK J, HUTCHINSON J, PARTLOW E. .. | 1 0.01 97.71 PITTENGER, C.. GABAPENTIN ABUSE, AND .. | 1 0.01 97.72 POGLIANI D, POZZI A, LAUDI C, RIMOLDI.. | 1 0.01 97.73 POGLIANI D, POZZI A, LAUDI C, RIMOLDI.. | 1 0.01 97.74 POGLIANI, D.. NONCONVULSIVE STATUS EP.. | 1 0.01 97.75 POLASEK TM ET AL. MULTIPLE DRUGS: VAR.. | 1 0.01 97.76 POLLOCK AJ, SEIBERT T, ALLEN DB. SEVE.. | 1 0.01 97.77 PONZETTI A, PINTA F, SPADI R, MECCA C.. | 1 0.01 97.78 PONZETTI A, PINTA F, SPADI R, MECCA C.. | 1 0.01 97.79 PONZETTI A, PINTA F, SPADI R, MECCA C.. | 1 0.01 97.80 PONZETTI A,PINTA F,SPADI R,MECCA C,FA.. | 1 0.01 97.81 PONZETTI, A.. JAW OSTEONECROSIS ASSOC.. | 1 0.01 97.82 PRIOTY I, CATHERINE D, LAUREN S, ADAM.. | 1 0.01 97.83 PRIYA SS, DL B, T S. ZOLPIDEM INDUCED.. | 1 0.01 97.84 PSENAK O, STUDNICKA-BENKE A, GREIL R... | 1 0.01 97.85 PUCHE MORENILLA C, CEBREIRO LOPEZ I, .. | 1 0.01 97.86 PURSNANI, A.. FATAL HYPERSENSITIVITY .. | 1 0.01 97.87 RABBONE I, GALDERISI A, TINTI D, IGNA.. | 1 0.01 97.88 RADU C, BARNIG C, DEBLAY F. RIVAROXAB.. | 1 0.01 97.89 RAJARAM, M.. HEPATITIS, RHABDOMYOLYSI.. | 1 0.01 97.90 RAMADAN AR, MEHTA C, HAWLEY M, VARELA.. | 1 0.01 97.91 RASENACK R, GAUPP N, RAUTENBERG B, ST.. | 1 0.01 97.92 REESE S, GRUNDFAST K. MINOCYCLINE-IND.. | 1 0.01 97.93 REICHLE A, VOGELHUBER M, HART C, HAHN.. | 1 0.01 97.94 REINA D, CERDA D, GUELL E, MARTINEZ M.. | 1 0.01 97.95 RENET S, CHAUMAIS M-C, ANTONINI T, ZH.. | 1 0.01 97.96 RENET S, CHAUMAIS M-C, ANTONINI T, ZH.. | 1 0.01 97.97 REPORTER KNOWN TO COMPANY. UNKNONW. U.. | 1 0.01 97.98 REPORTER KNOWN TO LICENSEE, PONTHIEUX.. | 1 0.01 97.99 REPPLINGER DJ, HERNANDEZ SH, HOFFMAN .. | 1 0.01 98.00 RICKNER S, SIMPSON S, CAO D. HEMOLYT.. | 1 0.01 98.01 RICKNER SS, ET A. AMOXICILLIN/PARACET.. | 1 0.01 98.02 RIEDEL T, GABRIELE E. LANG, SANDRA LI.. | 1 0.01 98.03 RIZZO R, GULISANO M, CALI PV. OCULOGY.. | 2 0.02 98.05 ROBERTS D R; LINDHORST S M; WELSH C T.. | 1 0.01 98.06 ROBINSON G, KASTE S, CHEMAITILLY W, B.. | 1 0.01 98.07 ROMESSER PB, SHERMAN EJ, SHAHA AR, L.. | 1 0.01 98.08 ROSADA J, REBELOS E, PETRUCCELLI S, T.. | 1 0.01 98.09 ROSENBLUM D, NOORI G, DESAN PH. RECUR.. | 1 0.01 98.10 ROSSI F, TURAZZINI M, RICCI S, POLO A.. | 1 0.01 98.11 ROTMAN, A.. SUDDEN SENSORINEURAL HEAR.. | 1 0.01 98.12 RUANGKANCHANASETR, P.. BIOPSY-PROVEN .. | 1 0.01 98.13 RUGGIERO NA, KISH TD, LEE ML. METFORM.. | 1 0.01 98.14 SAFARI M, HOSSEINI F ANTICONVULSIVE H.. | 1 0.01 98.15 SAGAWA N, MUKAIDOKORO J, HIYAMA M, IK.. | 1 0.01 98.16 SAINI R, CHANDRAGOUDA D, TALWAR V, RA.. | 1 0.01 98.17 SAITO T. A CASE OF HYPOGLYCEMIA DEVEL.. | 1 0.01 98.18 SAKAI H, NOMURA W, SUGAWARA M. CERTOL.. | 1 0.01 98.19 SALAMI A, ASSOUAN C, KOUYATE M, KADRE.. | 1 0.01 98.20 SANTOS-GOMEZ M, LLORENS V, MESQUIDA M.. | 1 0.01 98.21 SATO M, KAMEI K, OGURA M, ISHIKURA K .. | 1 0.01 98.22 SATO M, KAMEI K, OGURA M, ISHIKURA K .. | 5 0.05 98.27 SATO M, TAIRA S.. A CASE OF PULMONARY.. | 1 0.01 98.28 SATO T, ET AL.. A CASE OF DIFFUSE WAL.. | 1 0.01 98.29 SBRANA F, GENOVESI D, CATAPANO G, PAN.. | 1 0.01 98.30 SBRANA F,GENOVESI D,CATAPANO G,PANCHE.. | 1 0.01 98.31 SCHATTNER A, KITROSER E, COHEN J. FAT.. | 1 0.01 98.32 SCHMIDT TW, GARFINKLE M, BATTAFARANO .. | 1 0.01 98.33 SCHNEIDER R, BELLENBERG B, HOEPNER R,.. | 1 0.01 98.34 SCHNEIDER R, BELLENBURG B, HOEPNER R,.. | 1 0.01 98.35 SCHNEIDER R, BELLENBURG B, HOEPNER R,.. | 1 0.01 98.36 SHAH S, CARTER-MONROE N, ATTA MG. GRA.. | 1 0.01 98.37 SHAH, A.. EPIDURAL STEROID INJECTION .. | 1 0.01 98.38 SHAH, N.. SEROTONIN SYNDROME PRESENTI.. | 1 0.01 98.39 SHAHANI L. RHODOCOCCUS EQUI PNEUMONIA.. | 1 0.01 98.40 SHARON N, CULLEN C, MARTINEZ K. A COM.. | 1 0.01 98.41 SHARON, N.. A COMPLEX PRESENTATION OF.. | 1 0.01 98.42 SHASTAY A. PRESCRIBING ERRORS WITH LE.. | 1 0.01 98.43 SHEIKH M, NELSON-PIERCY C, DULEY J, F.. | 2 0.02 98.45 SHEIKH M, PAWAR SS, NORONHA C. PREDNI.. | 1 0.01 98.46 SHEN J, O^KEEFE K, WEBB LB, DEGIROLAM.. | 1 0.01 98.47 SHIMIZU, M.. DISPROPORTIONATE PULMONA.. | 1 0.01 98.48 SHIMONO C. A CASE OF RETROPERITONEAL .. | 1 0.01 98.49 SHIMZU M, NAKAGISHI Y, INOUE N, MIZUT.. | 1 0.01 98.50 SHIN S, KIM Y, LIM Y, LEE J, LEE J, K.. | 1 0.01 98.51 SHINICHI T, MASAYA O, TAKAYO U, TSUYO.. | 1 0.01 98.52 SHINOHARA, SATOSHI. CARDIAC ARREST DU.. | 1 0.01 98.53 SHINOZAKI T. EXPERIENCE OF EARLY ABIR.. | 1 0.01 98.54 SHINTANI, D.. ACUTE PANCREATITIS INDU.. | 1 0.01 98.55 SHIRVALKAR P, CHENG NT, LAHIRI S, DWU.. | 1 0.01 98.56 SHODA K, NONAKA Y, KATO M, TAKENAKA K.. | 1 0.01 98.57 SIMPAO AF, JANIK LS, HSU G, SCHWARTZ .. | 1 0.01 98.58 SINNECKER T, OTHMAN J, KUHL M, MEKLE .. | 1 0.01 98.59 SIQUEIRA AM, ALEXANDRE MAA, MOURAO MP.. | 1 0.01 98.60 SISE M, BACKMAN E,ORTIZ G, HUNDEMER G.. | 1 0.01 98.61 SKALSKI JH, KERN RM, MIDTHUN DE, EDEL.. | 1 0.01 98.62 SOLMAZ S, GOKGOZ Z, GEREKLIOGLU C, YE.. | 1 0.01 98.63 SOLOMON, A. INFLAMMATORY NEUROLOGICAL.. | 1 0.01 98.64 SONODA A, WADA K, MIZUKAMI K, FUKUDA .. | 1 0.01 98.65 SORENSON E, HOLTZMAN R, PATEL V, LOGA.. | 1 0.01 98.66 STEFOSKI D. IMMUNOSTIMULATORY EFFECT .. | 1 0.01 98.67 SUAREZ-DE-LA RICA A, HERNANDEZ-GANCED.. | 1 0.01 98.68 SUDA G, SAKAMOTO N, FURUYA K. REVIEW .. | 1 0.01 98.69 SUEMORI K, FUJIWARA H, WATANABE S, A.. | 1 0.01 98.70 SUGIMOTO S, ET AL. A CASE OF CHRONIC .. | 1 0.01 98.71 SUZUKI K, YAJIMA H, SUGANO S, WAKASUG.. | 1 0.01 98.72 T NEGISHI. PHARMACOLOGICAL AND SURGIC.. | 1 0.01 98.73 TADA H, OGIHARA T, SASAYAMA D, ET AL... | 1 0.01 98.74 TAE JOON LIM. LIFE-THREATENING COMPLI.. | 2 0.02 98.76 TAE, J.L.. LIFE-THREATENING COMPLICAT.. | 1 0.01 98.77 TAKAHASHI, N.. LONG-TERM TREATMENT WI.. | 1 0.01 98.78 TAKAHASHI, Y.. POTENTIAL RISK FACTORS.. | 8 0.08 98.86 TAKAOKA T, HIRATA Y, MASUZAWA A, IWAS.. | 1 0.01 98.87 TALEMAL L, OLIVIERI L, KRISHNAN A. DU.. | 1 0.01 98.88 TAMADA S, IGUCHI T, TACHIBANA H, NAKA.. | 1 0.01 98.89 TAN, L.. BILATERAL HUMERAL FRACTURES .. | 1 0.01 98.90 TANG, X.. SUCCESSFUL TREATMENT OF REL.. | 1 0.01 98.91 TANIOKA H, TSUJI A, EMI Y, MOTOTSUGU .. | 1 0.01 98.92 TANSY J, LUCAS M, LUCAS A, HOLLINGSWO.. | 1 0.01 98.93 TANTISATTAMO E, CHOKECHANACHAISAKUL A.. | 1 0.01 98.94 TARANTINI A.. BILATERAL SIMULTANEOUS .. | 1 0.01 98.95 TATTOLI L, KROCKER K, SAUTTER J, TSOK.. | 1 0.01 98.96 TEIXEIRA M, BONNICHSEN C. INSIDE-OUT:.. | 1 0.01 98.97 TERADA A. A CHILD CASE OF XERODERMA .. | 1 0.01 98.98 THAKER PH, BRADY WE, BRADLEY WH, ANWE.. | 1 0.01 98.99 THOMAS B, DHAILLE F, DUVERTLEHEMBRE S.. | 1 0.01 99.00 THOMSEN R. | 1 0.01 99.01 THOMSEN S, THOMSEN S. SUCCESSFUL AND .. | 1 0.01 99.02 THORNTON SL, CLARK RF. ENCEPHALOPATHY.. | 1 0.01 99.03 THORNTON SL, FARNAES L, MINNS A. PROL.. | 1 0.01 99.04 TINI P, NARDONE V, PASTINA P, BATTAGL.. | 2 0.02 99.06 TOKUYAMA K, ET AL. A CASE OF PYOGENIC.. | 1 0.01 99.07 TOMARI, S.. DEVELOPMENT OF INTERSTITI.. | 1 0.01 99.08 TOMIMITSU H,ITAYA S,SUZUKI M,HORI T,A.. | 1 0.01 99.09 TOMITA M, OBIGANE K, NARUGAMI M, ONO .. | 1 0.01 99.10 TONE S. THE 22ND SHIKOKU BRANCH SPECI.. | 1 0.01 99.11 TOPICAL MICONAZOLE, INCLUDING ORAL GE.. | 1 0.01 99.12 TOURIAN L JR, MARGOLESE HC, GAUTHIER .. | 2 0.02 99.14 TOYAMA S, ASANO Y, NAKAMURA K, ET AL... | 1 0.01 99.15 TRISCOTT J, MERCER S, TIAN PGJ, DOBBS.. | 1 0.01 99.16 TRISCOTT J, MERCER S, TIAN PGJ, DOBBS.. | 1 0.01 99.17 TROELSTRA N, RUTTEN A, DUISENBERG-VAN.. | 1 0.01 99.18 TSANG M, KARNA S. A CRYPTIC PRESENTAT.. | 1 0.01 99.19 TSUCHIMOTO A, MASUTANI K, MATSUKUMA Y.. | 1 0.01 99.20 TURATI M, GLARD Y, AFONSO D, GRIFFET .. | 1 0.01 99.21 TURNO-KRECICKA A, TOMCZYK-SOCHA M, ZI.. | 1 0.01 99.22 TWO CASES OF METFORMIN-ASSOCIATED LAC.. | 1 0.01 99.23 UNKNOWN. SIMVASTATIN: ACUTE RENAL FAI.. | 1 0.01 99.24 USLU U, HEPPT F, STICHERLING M. SECON.. | 1 0.01 99.25 UUSIMAA J, HINTTALA R, RANTALA H, ET .. | 1 0.01 99.26 VAN ZEEBURG E, CEREDA M AND VAN MEURS.. | 1 0.01 99.27 VANDAMME M, PAUWELS W, BLEECKER JD. A.. | 1 0.01 99.28 VANEGAS, N; HALLETT, M; ZAGHLOUL, KA;.. | 1 0.01 99.29 VARGAS-NERI JL, CASTELAN-MARTINEZ OD,.. | 1 0.01 99.30 VARGAS-NERI, J.. ANTHRACYCLINE-INDUCE.. | 2 0.02 99.32 VASAGAR B, VERMA BR, DEWBERRY RG, PUL.. | 1 0.01 99.33 VAZ R, BARROS F, TAVARES I, BUSTORFF .. | 1 0.01 99.34 VERA DANER D, BEDNARCZYK M, OLSON J. .. | 1 0.01 99.35 VIAL V, ANDINO R, ZEGPI MS, GONZALEZ .. | 1 0.01 99.36 VIARD T, DESTEPHEN C, KARE M, LABADIE.. | 1 0.01 99.37 VIARD T, DESTEPHEN C, KARE M, LABADIE.. | 1 0.01 99.38 VIARD, T.. RECURRENT HYPOGLYCEMIA DUE.. | 1 0.01 99.39 VICTORRI-VIGNEAU C, JOLLIET P.. SCORI.. | 1 0.01 99.40 VIGOA C M, PINEDOB G M, MONDRAG?NA C .. | 1 0.01 99.41 VIGOA C. M., PINEDOB G.M., MONDRAG?NA.. | 1 0.01 99.42 VIGOA C. M., PINEDOB G.M., MONDRAG?NA.. | 1 0.01 99.43 VILLANO JH, LOVELL EO. MIXED SIGNALS:.. | 1 0.01 99.44 VISHWAKARMA S, CHAURASIA R, SUBRAMANI.. | 1 0.01 99.45 VITALONE A,MENNITI-IPPOLITO F,MORO P... | 1 0.01 99.46 VIVAS L, GOLD W, MANDELL D, WU P. AN .. | 1 0.01 99.47 VIVEKANANDARAJAH A, KRISHNARASA B, MO.. | 1 0.01 99.48 VOICAN, C.. LIVER FUNCTION TEST ABNOR.. | 1 0.01 99.49 VON KUMMER R, ALLEN K, HOLLE R, BOZZA.. | 1 0.01 99.50 VOORE P, ODIGWE C, MIRRAKHIMOV AE, RI.. | 1 0.01 99.51 W TAN. A PHASE II TRIAL OF RITUXIMAB .. | 1 0.01 99.52 WALLACE KL, FILIPEK RL, LA HOZ RM, WI.. | 1 0.01 99.53 WALLACE KL, FILIPEK RL, LA HOZ RM, WI.. | 1 0.01 99.54 WALLACE, K. L.. SUBTHERAPEUTIC VORICO.. | 1 0.01 99.55 WANG Q, DAVIS D, PUTNAM PJ. THE AGONY.. | 1 0.01 99.56 WANG, K.L.. SYMPATHETIC NEUROPATHY AN.. | 1 0.01 99.57 WASSENAAR, S.. LETTER TO THE EDITOR I.. | 1 0.01 99.58 WASZKIEWICZ M, NAWROCKA I, KACZYNSKA .. | 1 0.01 99.59 WEI S,XIANGLI C,LIHONG L,SHUANG Q,YIN.. | 1 0.01 99.60 WEILER DL. ZONISAMIDE-INDUCED ANGLE C.. | 1 0.01 99.61 WHEDON JM, RUGO NA, LUX K. CHALLENGES.. | 1 0.01 99.62 WIEGAND T,CHAMBERLIN S. TOXIN INDUCED.. | 1 0.01 99.63 WIEGAND TJ, CHAMBERLIN S. TOXIN INDUC.. | 1 0.01 99.64 WIEGAND TJ, CHAMBERLIN S. TOXIN INDUC.. | 1 0.01 99.65 WIEGAND, T.. TOXIN INDUCED MYOCARDIAL.. | 1 0.01 99.66 WILKINSON ST, CHANG S-B, FOLEY T, LIP.. | 1 0.01 99.67 WILLERMAIN F, DEFLORENNE C, BOUFFIOUX.. | 1 0.01 99.68 WILLIAMS, J.. SAFETY AND CLINICAL RES.. | 1 0.01 99.69 WINDON A, MA Q, AARONS C, SHROFF S. I.. | 1 0.01 99.70 WITTER D, MCCORD M, SURYADEVARA U. DE.. | 1 0.01 99.71 WOLSCHKE. EXP HEMATOL. EXP HEMATOL. 2.. | 1 0.01 99.72 WONGRAKPANICH S, LU ML, ROSENZWEIG A... | 1 0.01 99.73 WU CY, MITCHELL SR, SEYFRIED LS. QUET.. | 1 0.01 99.74 WUNDERLE KA, SANDS MJ. RADIATION RECA.. | 1 0.01 99.75 YAGINUMA H. CLINICAL EXPERIENCE WITH .. | 1 0.01 99.76 YAMAGUCHI K, TAKADA S, ASHIKARI D, MU.. | 1 0.01 99.77 YAMAGUCHI M. TWO CASES OF MALIGNANT T.. | 1 0.01 99.78 YAMAKAWA, H.. PULMONARY AND RETROPERI.. | 1 0.01 99.79 YAMAMURO M, ISHIMOTO I, YAHATA M, ET .. | 1 0.01 99.80 YANAMOTO M, NAGAO Y, MASUMOTO S, AKAG.. | 1 0.01 99.81 YASUDA, S.. AGGRESSIVE TAFRO SYNDROME.. | 1 0.01 99.82 YASUMASA K., MORIMOTO Y., HATANAKA N... | 1 0.01 99.83 YASUO Y. EFFICACY AND SAFETY OF RANIB.. | 1 0.01 99.84 YAU AHL, XIONG W, KO HH. COLLAGENOUS .. | 1 0.01 99.85 YLIKOTILA P, KETOLA RA, TIMONEN S, MA.. | 1 0.01 99.86 YOLANDE LUCIRE. ANTIDEPRESSANT-INDUCE.. | 2 0.02 99.88 YONEKURA K, MIYAGAWA S, SHIBANUMA M, .. | 1 0.01 99.89 YOSHIHARA M. TWO CASES OF LUNG ADENOC.. | 1 0.01 99.90 YOUNES A, CONNORS JM, PARK SI, FANALE.. | 1 0.01 99.91 YOUNES A, CONNORS JM, PARK SI, HUNDER.. | 1 0.01 99.92 YU W, SHAN P AND LI C OVERVIEW OF ADR.. | 1 0.01 99.93 YU X, FERNANDEZ H. DOPAMINE AGONIST W.. | 1 0.01 99.94 ZAKY W, DHALL G, JI L, HALEY K, ALLEN.. | 2 0.02 99.96 ZEIN H, JOSUE S. WORMS AND COMPLEMENT.. | 1 0.01 99.97 ZHANG P., AUSTIN E., THOMPSON M., LIN.. | 1 0.01 99.98 ZHANG, P.. CHALLENGES IN A LARGE MIXE.. | 1 0.01 99.99 [HATCH DM, ATITO-NARH E, HERSCHMILLER.. | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 19 Jun 2018